Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cell division is the fundamental biological process by which a parent cell splits to give rise to two daughter cells, ensuring the maintenance, growth, and repair of tissues, as well as genetic stability from generation to generation[1][7][9]. In eukaryotes, cell division occurs through mitosis (producing identical daughter cells) or meiosis (producing gametes with half the parent’s chromosome number)[5][7][9]. The process is highly regulated by key molecular complexes, including cyclin-dependent kinases (CDKs), cyclins, and ubiquitin ligases such as the anaphase-promoting complex/cyclosome (APC/C), with numerous checkpoints that monitor DNA integrity and fidelity of chromosome segregation[1][2][6][7]. Disruption of cell division control is a hallmark of cancer and many other diseases[1][2][5]. Because "general cell division" is a process, not a discrete molecular target, drugs act by modulating its regulators—thus “general cell division” itself is not directly druggable[2][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on General cell division.